In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sigma-Genosys Ltd.

Latest From Sigma-Genosys Ltd.

BCM Technologies Inc.

BCM Technologies, the for-profit venture arm of the Baylor College of Medicine, has a hands-on approach to university technology transfer has served both the medical school and external investors well. First round investors in BCMT's first 14 spin-offs earned a 35% internal rate of return.


Quorex Pharmaceuticals Inc.

Quorex Pharmaceuticals has discovered a regulatory molecule and signaling pathway that permits bacterial cells to sense when they have achieved the population density (a quorum) needed to initiate the successful infection of a host. It is developing compounds that disrupt that communication system, which is found in a range of pathogens, to prevent infection.



Combinatorial chemistry company Chemicus focuses on bottlenecks in lead optimization in the drug discovery process. Chemicus claims that its abacus system makes larger amounts of similar compounds necessary for evaluating "hits" further down the drug discovery line.

BioPharmaceutical Research and Development Strategies

Baylor College of Medicine

BCM Technologies likes to start companies whenever it can; licensing’s fine, too.

See All

Company Information

  • Industry
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
    • Synthesis Technologies, Production Processes